Skip Main Navigation
Page Content

Save This Event

Event Saved

Meet with… Novartis Venture Fund

JLABS Bay Area

Tuesday, June 20, 2017 from 10:30 AM to 1:00 PM (PDT)

 Meet with… Novartis Venture Fund

Ticket Information

Ticket Type Sales End Price Fee Quantity
Presentation & Lunch Only   more info Jun 19, 2017 $25.00 $2.37
Volunteer   more info Jun 13, 2017 Free $0.00

Share Meet with… Novartis Venture Fund

Event Details

Let's get more solutions to patients. The Johnson & Johnson Innovation, JLABS (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including corporate venture, VC's, Angels and other investment entities.

On June 20th Principal Christine Brennan and Life Sciences Investment and Operations Professional Giovanni Ferrara of the Novartis Venture Fund (NVF)team will be in attendance to give an overview presentation about the fund's key areas of interest and to meet 1-on-1 with companies that have been accepted after applying online.

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due May 19, 2017. Apply Here.

Program Overview:
The Novartis Venture Fund founded in 1996, currently manages over $750 Million in committed capital, and has investments in ~40 portfolio companies globally. NVF's strategy is to build a diverse portfolio of life science companies, across:

  • Biotechnology/biopharma
  • Medical device/diagnostics
  • Digital/eHealth

NVF is stage agnostic and engages in seed investments as well as later-stage investments, typically investing up to $15 - $20 million over the life of the company. In investing, NVF looks for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency.

Following the presentation, don't miss this opportunity to introduce yourself to the team during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with Novartis Venture Fund will provide an intimate forum to discuss your company

Speakers:
Christine Brennan | Principal, Novartis Venture Fund read bio»

Giovanni Ferrara | Life Sciences Investment and Operations Professional, Novartis Venture Fund read bio»



Agenda:
10:30 AM | Registration and Networking
11:00 AM | Presentation and Q&A
11:45 AM | Networking Lunch
1:00 - 5:00 PM | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due May 19, 2017. Apply Here.


Speaker Bios:

Christine Brennan | Principal, Novartis Venture Fund
Dr. Brennan joined the Novartis Venture Fund in November 2013. Prior to joining Novartis Venture Fund, Dr. Brennan spent 3 years at Vitae Pharmaceuticals as Chief Business Officer responsible for strategy & business development. Prior to Vitae, she spent 5 years at Novartis Institutes for BioMedical Research in Strategic Alliances, most recently as Executive Director and Head of Strategy & Operations. Prior to Novartis, she held positions in business development and marketing at the biopharmaceutical companies, EnVivo Pharmaceuticals (now FORUM Pharmaceuticals), Biovail (now Valeant Pharmaceuticals) and Cogent Neuroscience. In addition, she was Director atFidelity Biosciences Group (now F-Prime Capital Partners), a venture capital company. She received her Ph.D. in neuroscience from Dartmouth Medical School in 1995 and completed a postdoctoral fellowship at the National Institutes of Health in 1999.

Giovanni Ferrara | Life Sciences Investment and Operations Professional, Novartis Venture Fund
Giovanni Ferrara is a Venture Partner in Cambridge, MA, USA. He joined NVF from portfolio company Sorbent Therapeutics, where he was consulting Chief Business Officer and a consultant to leading west coast venture capital firms. Most recently, Giovanni was consulting Chief Business Officer to Sorbent Therapeutics. Previously, he was Managing Director and General Partner at Burrill & Company and began his venture capital career at GeneChem Management, where in addition to his investing responsibilities, he held operating positions in portfolio companies, including CEO of Targanta Therapeutics. He began his career in healthcare at a cancer treatment center researching experimental therapies. He received his MBA and MSc from McGill University. Giovanni serves on the boards of, E-scape, NeuroVia and Thesan Pharmaceuticals.

Fees:

Presentation
$25 | General Public
$35 | Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on June 20 (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Apply to meet one-on-one with representatives from Novartis Venture Fund.  Your application will be reviewed and you will be notified of acceptance on Monday June 6, 2017. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.


About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.

Venue:
JLABS @ SSF
329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It

Have questions about Meet with… Novartis Venture Fund? Contact JLABS Bay Area

Save This Event

Event Saved

When & Where


Johnson & Johnson Innovation, JLABS
329 Oyster Point Blvd
3rd Floor
South San Francisco, CA

Tuesday, June 20, 2017 from 10:30 AM to 1:00 PM (PDT)


  Add to my calendar

Organizer

JLABS Bay Area

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.